Therefore, it was speculated that DUXAP8 might exert biological functions in terms of inhibiting glycolysis and inducing apoptosis in AML by inhibiting the activation of the Wnt/β-catenin signaling pathway. This evidence concerns the gene DUXAP8 and acute myeloid leukemia.